"neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer

Name: "neoBREASTIM": Atezolizumab Plus RP1 Oncolytic Immunotherapy in the NeoAdjuvant Setting of Triple-Negative Breast Cancer
License: Public Domain

Institut Curie

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

triple negative breast neoplasms

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174862
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.